Mathias Gradl
1PUBLICATIONS
16CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (1)
Sort by Publication Date:
|Aug 06, 2025
Selectivity for TP53 signalling drives the mode of action of a highly potent N,O,O-tridentate naphthoquinone-based organo-ruthenium anticancer drug candidate.Alexander Rosner, Lukas Skos, Theresa Mendrina
Pageof 1
Frequent Collaborators
1 joint publications
Alexander Rosner
1 joint publications
Lukas Skos
1 joint publications
Dina Baier
1 joint publications
Yasmin Borutzki
1 joint publications
Heiko Geisler
1 joint publications
Thomas Mohr
1 joint publications
Anton Legin
1 joint publications
Michael A Jakupec
1 joint publications
Andrea Bileck
1 joint publications
Christopher Gerner
